.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recent clinical evidence suggests that sNfL and atrial fibrillation outcomes are inextricably linked. While serum neurofilament light chain (sNfL) is primarily known as a marker for neuronal injury, its role in predicting cardiovascular risk is becoming clearer. The Swiss Atrial Fibrillation Cohort (SWISS-AF) study recently provided definitive data on this association in a large patient population.
Researchers analyzed 2,311 patients with atrial fibrillation (AF) over a median of eight years. They found that sNfL levels significantly predict the risk of major vascular events (MVEs). Specifically, every doubling of sNfL concentrations increases the adjusted hazard ratio for cardiovascular death, nonfatal stroke, or myocardial infarction to 1.35. Consequently, this biomarker offers a unique perspective on the systemic health of AF patients.
Furthermore, the study highlighted that higher sNfL levels correlate with increased all-cause mortality and heart failure-related hospitalizations. Interestingly, these associations remained robust even after adjusting for traditional risk factors like age, renal function, and prior stroke history. Therefore, sNfL may serve as a powerful tool for clinicians to identify high-risk individuals who require closer monitoring.
Integrating sNfL into standard risk assessment could transform AF management. While current scores focus on clinical history, this blood-based biomarker captures active physiological injury. Additionally, its predictive value for non-neurological outcomes like heart failure suggests that sNfL reflects broader vascular and systemic stress. Clinicians can benefit from this objective measurement to refine patient prognosis and personalize care.
Monitoring sNfL levels can help clinicians identify AF patients at higher risk for cardiovascular death and heart failure, allowing for more intensive monitoring and earlier interventions.
No, latest research from the SWISS-AF cohort indicates it is also a strong independent predictor of major vascular events and all-cause mortality in patients with atrial fibrillation.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare consultation. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Serum neurofilament light chain (sNfL) is identified as a robust biomarker for predicting major vascular events and mortality in atrial fibrillation patient...
5 months ago
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
